Journal of Clinical Epidemiology
Volume 54, Issue 5 , Pages 470-474 , May 2001

Hyperglycemia as a risk factor of mortality in a middle-aged Finnish population

  • Ulla Rajala

      Affiliations

    • Department of Public Health Science and General Practice, Aapistie 1, University of Oulu, 90220 Oulu, Finland
    • Corresponding Author InformationCorresponding author. Tel.: +358-(0)8-5375011; fax: +358-(0)8-5375661
    • ,
  • Pentti Koskela

      Affiliations

    • National Public Health Institute, Department in Oulu, Oulu, Finland
    • ,
  • Sirkka Keinänen-Kiukaanniemi

      Affiliations

    • Department of Public Health Science and General Practice, Aapistie 1, University of Oulu, 90220 Oulu, Finland

Received 11 November 1999 ,Revised 11 July 2000 ,Accepted 21 August 2000.

References 

  1. Jarrett RJ, McCartney P, Keen H. The Bedford survey (ten year mortality rates in newly diagnosed diabetics, borderline diabetics and normoglycaemic controls and risk indices for coronary heart disease in borderline diabetics). Diabetologia. 1982;22:79–84
  2. Reunanen A. Mortality in type 2 diabetes. Ann Clin Res. 1983;15(Suppl 37):26–28
  3. Pyörälä K, Laakso M, Uusitupa M. Diabetes and atherosclerosis (an epidemiologic view). Diab Metab Rev. 1987;3:463–524
  4. Kleinman JC, Donahue RP, Harris MI, Finucane FF, Madans JH, Brock DB. Mortality among diabetics in a national sample. Am J Epidemiol. 1988;128:389–401
  5. Rosengren A, Welin L, Tsipogianni A, Wilhelmsen L. Impact of cardiovascular risk factors on coronary heart disease and mortality among middle aged diabetic men (a general population study). BMJ. 1989;299:1127–1131
  6. Balkau B, Eschwège E, Ducimetière P, Richard J-L, Warnet J-M. The high risk of death by alcohol related diseases in subjects diagnosed as diabetic and impaired glucose tolerance (the Paris prospective study after 15 years of follow-up). J Clin Epidemiol. 1991;44:465–474
  7. Knuiman MW, Welborn TA, Whittall DE. An analysis of excess mortality rates for persons with non-insulin-dependent diabetes mellitus in western Australia using the Cox proportional hazards regression model. Am J Epidemiol. 1992;135:638–648
  8. Stengård JH, Tuomilehto J, Pekkanen J, Kivinen P, Kaarsalo E, Nissinen A, et al. Diabetes mellitus, impaired glucose tolerance and mortality among elderly men (The Finnish cohorts of The Seven Countries Study). Diabetologia. 1992;35:760–765
  9. Balkau B, Eschwège E, Papoz L, Richard J-L, Claude J-R, Warnet J-M, et al. Risk factors for early death in non-insulin dependent diabetes and men with known glucose tolerance status. BMJ. 1993;307:295–299
  10. Tuomilehto J, Schranz A, Aldana D, Pitkäniemi J. The effect of diabetes and impaired glucose tolerance on mortality in Malta. Diabetic Med. 1994;1:170–176
  11. Yano K, Kagan A, McGee D, Rhoads GG. Glucose intolerance and nine-year mortality in Japanese men in Hawaii. Am J Med. 1982;72:71–80
  12. Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H. Mortality from coronary heart disease and stroke in relation to degree of glycaemia (the Whitehall study). BMJ. 1983;287:867–870
  13. Panzram G. Mortality and survival in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 1987;30:123–131
  14. Fontbonne AM, Eschwège EM. Insulin and cardiovascular disease. Paris Prospective Study. Diabetes Care. 1991;14:461–469
  15. Uusitupa M, Pyörälä K, Laakso M. Metabolic control and macrovascular disease. In:  Alberti KGMM, et al. editor. International textbook of diabetes mellitus. Oxford: Alden Press; 1992;p. 1471–1485
  16. Uusitupa MIJ, Niskanen LK, Sitonen O, Voutilainen E, Pyörälä K. Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects. Diabetologia. 1993;36:1175–1184
  17. Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H. Coronary-heart-disease risk and impaired glucose tolerance. The Whitehall study. Lancet. 1980;i:1373–1376
  18. Barrett-Connor E, Wingard DL, Criqui MH, Suarez L. Is borderline fasting hyperglycemia a risk factor for cardiovascular death?. J Chron Dis. 1984;37:773–779
  19. Pyörälä K, Savolainen E, Kaukola S, Haapakoski J. Plasma insulin as coronary heart disease risk factor (relationship to other risk factors and predictive value during 9 1/2-year follow-up of the Helsinki policemen study population). Acta Med Scand. 1985;Suppl) 701:38–52
  20. Donahue RP, Abbott RD, Reed DM, Yano K. Postchallenge glucose concentration and coronary heart disease in men of Japanese ancestry. Honololu Heart Program. Diabetes. 1987;36:689–692
  21. Vaccaro O, Ruth KJ, Stamler J. Relationship of postload plasma glucose to mortality with 19-yr follow-up. Diabetes Care. 1992;15:1328–1334
  22. Yarnell JWG, Pickering JE, Elwood PC, Baker IA, Bainton D, Dawkins C, et al. Does non-diabetic hyperglycemia predict future IHD? Evidence from the Caerphilly and Speedwell studies. J Clin Epidemiol. 1994;47:383–388
  23. Jarrett RJ. The cardiovascular risk associate with impaired glucose tolerance. Diabetic Med. 1996;13:S15–S19
  24. World Health Organization. Diabetes mellitus: report of a WHO Study Group. Geneva: World Health Org. 1985 (Tech. Rep. Ser., no 727).
  25. The expert committee on the diagnosis and classification of diabetes mellitus . Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 1997;20:1183–1197
  26. Alberti KGMM, Zimmet PZ, for the WHO Consultation. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation. Diabetic Med 1998;15:539–53.
  27. DECODE Study Group on behalf of the European Diabetes Epidemiology Study Group . Glucose tolerance and mortality (comparison of WHO and American Diabetic Association diagnostic criteria). Lancet. 1999;354:617–621
  28. Rajala U, Keinänen-Kiukaanniemi S, Uusimäki A, Kivelä S-L. Prevalence of diabetes mellitus and impaired glucose tolerance in a middle-aged Finnish population. Scand J Prim Health Care. 1995;13:222–228
  29. World Health Organization. Arterial hypertension. Geneva: World Health Org., 1978 (Tech. Rep. Ser., no 628).
  30. Cox DR, Oakes D. Analysis of survival data. New York: Chapman and Hall; 1984;
  31. Fontbonne A, Charles MA, Thibult N, et al.  Hyperinsulinaemia as a predictor of coronary heart disease mortality in a healthy population (the Paris Prospective Study, 15-year follow-up). Diabetologia. 1991;34:356–361
  32. Yusuf HR, Giles WH, Croft JB, Anda RF, Casper ML. Impact of multiple risk factor profiles on determining cardiovascular disease risk. Preventive Medicine. 1998;27:1–9
  33. Wingard DL. The sex differential in morbidity, mortality, and lifestyle. Ann Rev Public Health. 1984;5:433–458
  34. Koskenvuo M, Kaprio J, Lönnqvist J, Sarna S. Social factors an the gender difference in mortality. Soc Sci Med. 1986;23:605–609

PII: S0895-4356(00)00324-3

Journal of Clinical Epidemiology
Volume 54, Issue 5 , Pages 470-474 , May 2001

Article Tools